FDA Amends Pembrolizumab Indication in Gastric Cancer ...Middle East

News by : (Medscape) -
The revised indication is based on recent findings from a prespecified interim analysis showing little benefit in patients whose tumors do not express PD-L1. Medscape Medical News

Hence then, the article about fda amends pembrolizumab indication in gastric cancer was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Amends Pembrolizumab Indication in Gastric Cancer )

Last updated :

Also on site :

Most Viewed News
جديد الاخبار